Risk Factors, Predictive Markers and Prevention Strategies for Intrauterine Fetal Death. An Integrative Review
Abstract
:Introduction
Discussions
Fetal growth restriction and intrauterine fetal death
Prolonged labor and fetal death
Pathology and intrauterine fetal death
- Single umbilical artery—This diagnosis is based on the visualization of a single vessel around the fetal bladder, occurring in about 0.5% of pregnancies. This characteristic has been associated with maternal diabetes, smoking, and seizure disorders [34,35]. The outcome of such cases is influenced by the associated conditions. Single umbilical artery without other anomalies does not demonstrate a statistically significant increase in fetal, neonatal, and infant death [20], but results in an increased risk when associated with anatomical and chromosomal anomalies. Recommended antepartum fetal monitoring, in the absence of other associated conditions, involves following fetal growth every 4-6 weeks, as there is a significant association between single umbilical artery and intrauterine growth restriction. A postnatal renal screening of infants should also be considered if the kidneys were poorly visualized on prenatal ultrasound [36,37].
- Hypoplasia of one umbilical artery may occasionally be diagnosed during ultrasound screening. There is no standard definition for the disparity between the sizes of the umbilical arteries. This condition has a higher prevalence in the high-risk population, and thus screening for other fetal anomalies should be performed.
- Aneurysm and varix of the umbilical cord have a low incidence, but they are also highly associated with fetal demise through rupture, intra-amniotic hemorrhage, and fetal exsanguination [21,38]. If this abnormality is diagnosed prenatally, frequent fetal monitoring with non- stress testing, ultrasound, and delivery after lung maturation are indicated [22,23].
- Velamentous cord insertion has a prevalence of 1% in singleton pregnancies, and it can be diagnosed through prenatal ultrasound examination by observing the umbilical cord insertion several centimeters from the placenta at the point where the umbilical vessels divide [39]. Fetal death can occur when fetal membranes rupture, which can lead to the rupture of the umbilical vessels, especially in the case of vasa previa [25,40]. Considering these complications, if the ultrasound examination suggests velamentous cord insertion, a detailed ultrasound screening is required for the evaluation of coexisting vasa previa. Moreover, serial assessment of fetal growth, weekly non-stress testing after 36 weeks of gestation, and delivery at 40 weeks of gestation are also recommended. Specifically, these cases require continuous intrapartum fetal heart monitoring [41,42,43].
- True knot in the cord is associated with a high risk of fetal demise if the knot is tight or multiple [44,45]. These pregnancies require close monitoring particularly in the last trimester, with serial ultrasound examinations that include Doppler evaluation, assessment of fetal growth, determining amniotic fluid index, biophysical profile scoring, and non-stress testing.
- Abruptio placentae affects about 1% of pregnancies, with the sensitivity of a prenatal ultrasound for this condition at only 25-60% [27,46]. Chronic abruption is associated with a high risk for fetal growth restriction and all the consequences of this pathology, whereas acute abruption has a perinatal mortality of 3 to 12%, with more that 50% of these cases ending in stillbirth [47]. The diagnosis is mainly clinical, and the details of management include continuous fetal monitoring, secure intravenous access, monitoring the maternal hemodynamic status, and evaluating for coagulopathy [48,49]. Subsequent medical decisions will depend on fetal and maternal status. Immediate delivery is recommended if the fetal heart rate pattern is non-reassuring or ominous. If the mother and the fetus are stable, but an abruption placenta is suspected, delivery is suggested for pregnancies after 34 weeks of gestation, as the benefits of delivery at this time surpass the risks. Because the risk of recurrence of this pathology (3-15%) is common, a subsequent pregnancy for the patient should be considered a high-risk pregnancy.
- Placenta previa is associated with a 3-5 times increased risk of preterm birth [50,51]; thus perinatal and neonatal morbidity and mortality are directly related to prematurity complications. In order to reduce neonatal morbidity and mortality rates, the administration of antenatal corticosteroids before 34 weeks of gestation is recommended for all placenta previa cases, and planned late preterm cesarean delivery should be considered. Several characteristics appear predictive of antepartum bleeding, including a cervical length less than 3 centimeters, and a decrease in cervical length in the last trimester, as well as a thick placental edge with echo free space over the internal os [52].
Post-term pregnancy
Gestational diabetes
Infections
Conclusions
- Periconceptional supplementation with folic acid
- Prevention of malaria in endemic areas
- Screening for and treatment of syphilis
- Detection, prevention, and treatment of hypertensive disorders of pregnancy
- Detection and appropriate management of gestational diabetes
- Screening, monitoring, and management of pregnancies complicated with intrauterine growth restriction
- Identification and induction of post-term pregnancies
- Delivery in a specialized unit assisted by a skilled birth attendant
- Capacity for possible basic emergency obstetric care
- Capacity for possible comprehensive emergency obstetric care.
Conflicts of Interest
Compliance with Ethical Standards
References
- Joseph, K.; Kinniburgh, B.; Hutcheon, J.A.; Mehrabadi, A.; Dahlgren, L.; Basso, M.; Davies, C.; Lee, L. Rationalizing Definitions and Procedures for Optimizing Clinical Care and Public Health in Fetal Death and Stillbirth. Obstet. Gynecol. 2015, 125, 784–788. [Google Scholar] [CrossRef]
- Lawn, J.E.; Blencowe, H.; Pattinson, R.; Cousens, S.; Kumar, R.; Ibiebele, I.; et al. Stillbirths: Where? When? Why? How to make the data count? The Lancet. 2011, 377, 1448–1463. [Google Scholar] [CrossRef] [PubMed]
- Fretts, R.C.; Schmittdiel, J.; McLean, F.H.; Usher, R.H.; Goldman, M.B. Increased maternal age and the risk of fetal death. N Engl J Med. 1995, 333, 953–957. [Google Scholar] [CrossRef]
- McClure, E.M.; Nalubamba-Phiri, M.; Goldenberg, R.L. Stillbirth in developing countries. Int J Gynaecol Obstet 2006, 94, 82–90. [Google Scholar] [CrossRef] [PubMed]
- Huang, D.Y.; Usher, R.H.; Kramer, M.S.; Yang, H.; Morin, L.; Fretts, R.C. Determinants of unexplained antepartum fetal deaths. Obstet Gynecol. 2000, 95, 215–221. [Google Scholar] [CrossRef]
- Bumbu, A.; Nacer, K.; Bratu, O.; Berechet, M.; Bumbu, G.; Bumbu, B. Ureteral lesions in gynecological pathology. Proceedings of the 14th national congress of urogynecology and the national conference of the Romanian association for the study of pain. Filodiritto publisher 2017, 82–89. [Google Scholar]
- Alexandroaia, C.; Sima, R.-M.; Bălălău, O.-D.; Olaru, G.O.; Pleş, L. Patients’ perception of childbirth according to the delivery method: The experience in our clinic. J. Mind Med Sci. 2019, 6, 311–318. [Google Scholar] [CrossRef]
- Nacer, K.; Bratu, O.; Berechet, M.; Bumbu, G.; Bumbu, A. Global surgical principles in the vaginal approach of advanced pelvic organ prolapse. Proceedings of the 14th national congress of urogynecology and the national conference of the Romanian association for the study of pain. Filodiritto publisher 2017, 172–180. [Google Scholar]
- Zeitlin, J.; El Ayoubi, M.; Jarreau, P.H.; et al. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr. 2010, 157, 733–739.e1. [Google Scholar] [CrossRef]
- Ghaleb, M.; Bouaziz, H.; Sghaier, S.; Slimane, M.; Bouzaiene, H.; Ben Hassouna, J.; Ben Dhiab, T.; Hechiche, M.; Chargui, R.; Rahal, K. Ovarian cancer: Is an expert surgical oncologist mandatory? J Clin Invest Surg. 2019, 4, 58–65. [Google Scholar] [CrossRef]
- Ray, J.G.; Park, A.L.; Fell, D.B. Mortality in Infants Affected by Preterm Birth and Severe Small-for- Gestational Age Birth Weight. Pediatrics. 2017, 140, e20171881. [Google Scholar] [CrossRef] [PubMed]
- Bohiltea, R.; Furtunescu, F.; Turcan, N.; et al. Prematurity and Intrauterine Growth Restriction: Comparative Analysis of Incidence and Short-Term Complication. Proceedings of SOGR. The 17th national congress of the Romanian society of obstetrics and gynecology. 2018; pp. 20–22. [Google Scholar]
- Simionescu, A.A.; Marin, E. Postpartum depression and thyroid dysfunction– should pregnant women be screened for thyroid disorders? J Mind Med Sci. 2019, 6, 103–109. [Google Scholar] [CrossRef]
- Bohiltea, R.; Turcan, N.; Ionescu, C.; et al. The incidence of prematurity and associated short-term complications in a multidisciplinary emergency hospital from Romania 5th Romanian Congress of the Romanian Society of Ultrasound in Obstetrics and Gynecology, Targu Mures, Romania. 2017; pp. 105–112. [Google Scholar]
- Miller, C.M.; Cohn, S.; Akdagli, S.; Carvalho, B.; Blumenfeld, Y.J.; Butwick, A.J. Postpartum hemorrhage following vaginal delivery: risk factors and maternal outcomes. J Perinatol. 2017, 37, 243–248. [Google Scholar] [CrossRef]
- Laughon, S.K.; Berghella, V.; Reddy, U.M.; Sundaram, R.; Lu, Z.; Hoffman, M.K. Neonatal and maternal outcomes with prolonged second stage of labor [published correction appears in Obstet Gynecol. 2014 Oct; 124(4): 842]. Obstet Gynecol. 2014, 124, 57–67. [Google Scholar] [CrossRef]
- Grobman, W.A.; Bailit, J.; Lai, Y.; et al. Association of the Duration of Active Pushing With Obstetric Outcomes. Obstet Gynecol. 2016, 127, 667–673. [Google Scholar] [CrossRef]
- American College of Obstetricians and Gynecologists (College); Society for Maternal-Fetal Medicine; Caughey, A.B.; Cahill, A.G.; Guise, J.M.; Rouse, D.J. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol. 2014, 210, 179–193. [Google Scholar] [CrossRef]
- Chioveanu, M.; Bălălău, O.D.; Sima, R.M.; Pleș, L.; Bălălău, C.; Stănescu, A.D. Gestational diabetes—Diagnostic and therapeutic novelties. J Clin Invest Surg. 2019, 4, 66–71. [Google Scholar] [CrossRef]
- Lemos, A.; Amorim, M.M.; Dornelas de Andrade, A.; de Souza, A.I.; Cabral Filho, J.E.; Correia, J.B. Pushing/bearing down methods for the second stage of labour. Cochrane Database Syst Rev 2015, CD009124, Published 2015 Oct 9. [Google Scholar] [CrossRef]
- Naeye, R. Disorders of the Umbilical Cord; Mosby-Year Book Inc.: St Louis, MO, USA, 1992. [Google Scholar]
- Voskamp, B.J.; Fleurke-Rozema, H.; Oude-Rengerink, K.; et al. Relationship of isolated single umbilical artery to fetal growth, aneuploidy and perinatal mortality: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013, 42, 622–628. [Google Scholar] [CrossRef]
- White, S.P.; Kofinas, A. Prenatal diagnosis and management of umbilical vein varix of the intra- amniotic portion of the umbilical vein. J Ultrasound Med. 1994, 13, 992–994. [Google Scholar] [CrossRef]
- Stanciu, A.E.; Stanciu, M.M.; Vatasescu, R.G. NT- proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure. Cytokine. 2018, 111, 13–19. [Google Scholar] [CrossRef]
- Bohîlțea, R.; Cîrstoiu, M.; Ciuvica, A.; Munteanu, O.; et al. Veamentous insertion of umbilical cord with vasa praevia: case series and literature review. Journal of Medicine and Life 2016, 9, 552–562. [Google Scholar]
- Ciuhu, A.N.; Pantea-Stoian, A.M.; Nitipir, C.; et al. Assessment of cachexia in cancer patients with advanced disease. Conference: 3rd International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications (INTERDIAB) Location: Bucharest, ROMANIA Date: MAR 02-04, 2017. Sponsor(s): Assoc Renal Metab & Nutrit Studies; AstraZeneca Diabetes; MSD Diabetes; novo nordisk; SANOFI, INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE Book Series: International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications. 2017; pp. 139–147. [Google Scholar]
- Stanciu, A.E.; Vatasescu, R.G.; Stanciu, M.M.; Serdarevic, N.; Dorobantu, M. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Cytokine 2018, 103, 63–68. [Google Scholar] [CrossRef]
- Ghalleb, M.; Bouzaiene, H.; Seghaier, S.; Bouaziz, H.; Hechiche, M.; Chargui, R.; Khaled, R. Fertility sparing surgery for stage Ic ovarian cancer: An eight case series. J Clin Invest Surg. 2019, 4, 32–37. [Google Scholar] [CrossRef]
- Hasegawa, J.; Matsuoka, R.; Ichizuka, K.; Sekizawa, A.; Okai, T. Ultrasound diagnosis and management of umbilical cord abnormalities. Taiwan J Obstet Gynecol. 2009, 48, 23–27. [Google Scholar] [CrossRef] [PubMed]
- Bohîlțea, R.; Turcan, N.; Cîrstoiu, M. Prenatal ultrasound diagnosis and pregnancy outcome of umbilical cord knot—debate regarding ethical aspects of a series of cases. Journal of Medicine and Life. 2016, 9, 297–301. [Google Scholar]
- Glantz, C.; Purnell, L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. 2002, 21, 837–840. [Google Scholar] [CrossRef]
- Ananth, C.V.; Hansen, A.V.; Williams, M.A.; Nybo Andersen, A.M. Cardiovascular Disease in Relation to Placental Abruption: A Population-Based Cohort Study from Denmark. Paediatr Perinat Epidemiol. 2017, 31, 209–218. [Google Scholar] [CrossRef]
- Tveit, J.; Saastad, E.; Bordahl, P.; Stray-Pedersen, B.; Frøen, J. (Eds.) The epidemiology of decreased fetal movements. Annual conference of the Norwegian Perinatal Society, 2006.
- Vahanian, S.A.; Lavery, J.A.; Ananth, C.V.; Vintzileos, A. Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol. 2015, 213 (Suppl 4), S78–S90. [Google Scholar] [CrossRef]
- Ghi, T.; Contro, E.; Martina, T.; et al. Cervical length and risk of antepartum bleeding in women with complete placenta previa. Ultrasound Obstet Gynecol. 2009, 33, 209–212. [Google Scholar] [CrossRef] [PubMed]
- Mannino, F. Neonatal complications of postterm gestation. J Reprod Med. 1988, 33, 271–276. [Google Scholar] [PubMed]
- De Los Santos-Garate, A.; Villa-Guillen, M.; Villanueva-Garcia, D.; Vallejos-Ruiz, M.; Murguia-Peniche, M. Perinatal morbidity and mortality in late- term and post-term pregnancy. NEOSANO perinatal network’s experience in Mexico. Journal of Perinatology. 2011, 31, 789. [Google Scholar] [CrossRef] [PubMed]
- Haavaldsen, C.; Sarfraz, A.A.; Samuelsen, S.O.; Eskild, A. The impact of maternal age on fetal death: does length of gestation matter? Am J Obstet Gynecol. 2010, 203, 554.e1–554.e5548. [Google Scholar] [CrossRef]
- Chiriță, C.; Ștefănescu, E.; Zbârcea, C.E.; Mireșan, H.; Negreș, S.; Nuță, D.C.; Limban, C.; Dănciulescu Miulescu, R.E.; Marineci, C.D. Experimental pharmacological research regarding the antidepressant effect of associating doxepin and selegiline in normal mice. J Mind Med Sci. 2019, 6, 261–270. [Google Scholar] [CrossRef]
- Middleton, P.; Shepherd, E.; Crowther, C.A. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2018, 5, CD004945, Published 2018 May 9. [Google Scholar] [CrossRef]
- Langer, O.; Rodriguez, D.A.; Xenakis, E.M.; McFarland, M.B.; Berkus, M.D.; Arrendondo, F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol. 1994, 170, 1036–1047. [Google Scholar] [CrossRef]
- Pilliod, R.A.; Page, J.M.; Burwick, R.M.; Kaimal, A.J.; Cheng, Y.W.; Caughey, A.B. The risk of fetal death in nonanomalous pregnancies affected by polyhydramnios. Am J Obstet Gynecol. 2015, 213, 410.e1–410.e4106. [Google Scholar] [CrossRef]
- Suceveanu, A.I.; Stoian APantea Mazilu, L.; et al. Interferon-free therapy is not a trigger for hepatocellular carcinoma in patients with chronic infection with hepatitis C Virus. Farmacia 2018, 66, 904–908. [Google Scholar] [CrossRef]
- Caughey, A.B.T.M. Committee on Practice Bulletins- Obstetrics. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018, 131, e49–e64. [Google Scholar]
- Goldenberg, R.L.; McClure, E.M.; Saleem, S.; Reddy, U.M. Infection-related stillbirths. The Lancet. 2010, 375, 1482–1490. [Google Scholar] [CrossRef] [PubMed]
- Iwasenko, J.M.; Howard, J.; Arbuckle, S.; Graf, N.; Hall, B.; Craig, M.E.; et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. Journal of Infectious Diseases. 2011, 203, 1526–1533. [Google Scholar] [CrossRef]
- Andrei, C.A.; Scăunașu, R.V.; Simionescu, A.A.; Burcoș, T.; Lupușoru, M.D.; Lica, G. The incidence of haemorrhagic and thrombo-embolic events after breast cancer surgery in patients treated with pharmacological thrombo- prophylaxis. J Clin Invest Surg. 2019, 4, 10–18. [Google Scholar] [CrossRef]
- Hainarosie, R.; Zainea, V.; Rusescu, A.; et al. Management of infectious complications in diabetes mellitus mellitus patients. Romanian Journal of Military Medicine 2019, 122, 46–51. [Google Scholar] [CrossRef]
- Phares, C.R.; Lynfield, R.; Farley, M.M.; et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299, 2056–2065. [Google Scholar] [CrossRef] [PubMed]
- Kaku, S.; Tsuji, S.; Ono, T.; Kimura, F.; Murakami, T. Successful management of complete placenta previa after intrauterine fetal death in a second-trimester pregnancy by uterine artery embolization: case report and literature review. Clin Exp Obstet Gynecol. 2017, 44, 458–460. [Google Scholar] [CrossRef]
- Ben Amor, S.; Ben Mansour, W.; Ben Chaabane, N.; Baklouti, R.; Loghmari, M.H.; Safer, L. Interest of First Laparoscopy in the Etiological Diagnosis of Isolated Exudative Ascites. J Clin Invest Surg. 2019, 4, 19–26. [Google Scholar] [CrossRef]
- Iwase, J.; Yamanaka, M. Sudden onset of pheochromocytoma multisystem crisis at 38 weeks of gestation resulted in intrauterine fetal death: A case report. J Obstet Gynaecol Res. 2017, 43, 1644–1648. [Google Scholar] [CrossRef]
- Maignien, C.; Nguyen, A.; Dussaux, C.; Cynober, E.; Gonzales, M.; Carbonne, B. Outcome of pregnancy following second- or third-trimester intrauterine fetal death. Int J Gynaecol Obstet. 2014, 127, 275–278. [Google Scholar] [CrossRef]
- Petrosellini, C.; Hameed, A. Intrauterine death at term in a cocaine user detained under the Mental Health Act. BMJ Case Rep. 2015, 2015, bcr2015212403, Published 2015 Dec 9. [Google Scholar] [CrossRef]
- Joseph, K.S.; Basso, M.; Davies, C.; et al. Rationale and recommendations for improving definitions, registration requirements and procedures related to fetal death and stillbirth. BJOG. 2017, 124, 1153–1157. [Google Scholar] [CrossRef] [PubMed]
- Williams, E.J.; Embleton, N.D.; Clark, J.E.; Bythell, M.; Ward Platt, M.P.; Berrington, J.E. Viral infections: contributions to late fetal death, stillbirth, and infant death. J Pediatr. 2013, 163, 424–428. [Google Scholar] [CrossRef] [PubMed]
- Motofei, I.G.; Rowland, D.L.; Manea, M.; Georgescu, S.R.; Păunică, I.; Sinescu, I. Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain. Clin Drug Investig. 2017, 37, 511–517. [Google Scholar] [CrossRef] [PubMed]
- Pilliod, R.A.; Cheng, Y.W.; Snowden, J.M.; Doss, A.E.; Caughey, A.B. The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol. 2012, 207, 318. e1–318. e3186. [Google Scholar] [CrossRef]
- Budin, C.E.; Ciumarnean, L.; Maierean, A.; Rajnovean, R.; Gergely, B.D.; Man, M.; Aluas, M.; Cozma, A.; Bordea, R.I. Therapeutic alternatives with CPAP in obstructive sleep apnea. J Mind Med Sci. 2019, 6, 181–189. [Google Scholar] [CrossRef]
- Haavaldsen, C.; Samuelsen, S.O.; Eskild, A. Fetal death and placental weight/birthweight ratio: a population study. Acta Obstet Gynecol Scand. 2013, 92, 583–590. [Google Scholar] [CrossRef]
- Schreiber, C.A.; Creinin, M.D.; Atrio, J.; Sonalkar, S.; Ratcliffe, S.J.; Barnhart, K.T. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss. N Engl J Med. 2018, 378, 2161–2170. [Google Scholar] [CrossRef]
- Norman, J.E.; Heazell, A.E.P.; Rodriguez, A.; et al. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster- randomised trial. Lancet. 2018, 392, 1629–1638. [Google Scholar] [CrossRef]
- Chappell, L.C.; Bell, J.L.; Smith, A.; et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): A randomised controlled trial. Lancet 2019, 394, 849–860. [Google Scholar] [CrossRef]
- Chaudhuri, P.; Datta, S. Mifepristone and misoprostol compared with misoprostol alone for induction of labor in intrauterine fetal death: A randomized trial. J Obstet Gynaecol Res. 2015, 41, 1884–1890. [Google Scholar] [CrossRef]
- Ahlenius, I.; Floberg, J.; Thomassen, P. Sixty-six cases of intrauterine fetal death. A prospective study with an extensive test protocol. Acta Obstet Gynecol Scand. 1995, 74, 109–117. [Google Scholar] [CrossRef] [PubMed]
Characteristic | Group 1 | Group 2 | Group 3 | Total | P Value | ||||
---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | ||
Total subjects | 78 | 6% | 1,121 | 80% | 206 | 15% | 1,405 | 100% | |
Males | 37 | 3% | 573 | 41% | 85 | 6% | 695 | 49% | 0.032 |
Demise | 14 | 18% | 51 | 5% | 2 | 1% | 67 | 5% | <0.001 |
© 2020 by the author. 2020 Roxana Bohiltea, Natalia Turcan, Christina M. Cavinder, Ionită Ducu, Ioana Paunica, Liliana Florina Andronache, Monica Mihaela Cirstoiu.
Share and Cite
Bohiltea, R.; Turcan, N.; Cavinder, C.M.; Ducu, I.; Paunica, I.; Andronache, L.F.; Cirstoiu, M.M. Risk Factors, Predictive Markers and Prevention Strategies for Intrauterine Fetal Death. An Integrative Review. J. Mind Med. Sci. 2020, 7, 52-60. https://doi.org/10.22543/7674.71.P5260
Bohiltea R, Turcan N, Cavinder CM, Ducu I, Paunica I, Andronache LF, Cirstoiu MM. Risk Factors, Predictive Markers and Prevention Strategies for Intrauterine Fetal Death. An Integrative Review. Journal of Mind and Medical Sciences. 2020; 7(1):52-60. https://doi.org/10.22543/7674.71.P5260
Chicago/Turabian StyleBohiltea, Roxana, Natalia Turcan, Christina M. Cavinder, Ionită Ducu, Ioana Paunica, Liliana Florina Andronache, and Monica Mihaela Cirstoiu. 2020. "Risk Factors, Predictive Markers and Prevention Strategies for Intrauterine Fetal Death. An Integrative Review" Journal of Mind and Medical Sciences 7, no. 1: 52-60. https://doi.org/10.22543/7674.71.P5260
APA StyleBohiltea, R., Turcan, N., Cavinder, C. M., Ducu, I., Paunica, I., Andronache, L. F., & Cirstoiu, M. M. (2020). Risk Factors, Predictive Markers and Prevention Strategies for Intrauterine Fetal Death. An Integrative Review. Journal of Mind and Medical Sciences, 7(1), 52-60. https://doi.org/10.22543/7674.71.P5260